(Q36034740)

11 August 2017

1 reference

title

Fondaparinux: an update on new study results (English)

1 reference

11 August 2017

Bauersachs RM

1

1 reference

11 August 2017

publication date

1 March 2005

1 reference

European Journal of Clinical Investigation

11 August 2017

published in

1 reference

11 August 2017

volume

35 Suppl 1

1 reference

11 August 2017

page(s)

27-32

1 reference

A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2005.01454.X

Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2005.01454.X

Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2005.01454.X

Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2005.01454.X

Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2005.01454.X

Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2005.01454.X

Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2005.01454.X

Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2005.01454.X

Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2005.01454.X

Secondary prophylaxis with warfarin for venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2005.01454.X

A synthetic factor-Xa inhibitor (ORG31540/SR9017A) as an adjunct to fibrinolysis in acute myocardial infarction. The PENTALYSE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2005.01454.X

A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0960-135X.2005.01454.X

10.1111/J.0960-135X.2005.01454.X

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference